patent/EP-0118565-A4

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e45efeaa6a34dfd9d44fa29a7fe0c806
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-80
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-80
filingDate	1983-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41187c6704099c874b6a661e599107cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64a7340be410ed39a766e04e632d604e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d39faf23bf7e9b771eed47a44ddb5052
publicationDate	1985-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	EP-0118565-A4
titleOfInvention	1,4-METHANO-2-BENZAZEPINE DERIVATIVES.
abstract	1,4-Methano-2,3,4,5-tetrahydro-1H-2-benzazepine-3-one derivatives represented by the general formula (I), wherein X represents halogen, n represents 1 or 2, and R represents hydrogen, lower alkyl or phenyl-substituted lower alkyl. They are useful as brain function-improving agents, antispasmodics, antiepileptics, tranquilizers, etc.
priorityDate	1982-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3291806-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3600400-A
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420020479 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420020471 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236062665 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20264052 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70490828

Total number of triples: 20.